The research team created a point-of-care assay that can detect bacterial STIs, including chlamydia and gonorrhea.
A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...